Epidural stimulation for peripheral vascular disease: 10 years experience

Area of Science:

• Vascular Surgery
• Neuromodulation
• Peripheral Vascular Disease Management

Background:

• Peripheral vascular disease (PVD) significantly impacts patient quality of life, often leading to severe ischemic pain.
• Epidural spinal stimulation (ESS) has emerged as a potential treatment modality for refractory PVD symptoms.
• Patient selection criteria for ESS in PVD have evolved over time, influencing treatment efficacy.

Purpose of the Study:

• To evaluate the efficacy of epidural spinal stimulation (ESS) in patients with arteriosclerotic peripheral vascular disease (PVD).
• To compare outcomes based on patient selection criteria before and after 1986.
• To determine optimal patient profiles for successful ESS treatment in advanced PVD.

Main Methods:

• Retrospective analysis of 105 patients with arteriosclerotic PVD treated with ESS over 10 years.
• Categorization of patients into two groups: pre-1986 (ischemic pain focus) and post-1986 (stage-based selection).
• Assessment of treatment outcomes based on clinical improvement and disease stage.

Main Results:

• Patients selected after 1986, with more accurate staging, demonstrated more favorable outcomes with ESS.
• The study observed a trend towards better results when patients were chosen based on disease severity.
• No specific mention of necrosis or large trophic lesions in the improved outcomes group.

Conclusions:

• Epidural spinal stimulation is a viable treatment for advanced peripheral vascular disease (PVD).
• Careful patient selection, focusing on Fontaine stage III and IV without necrosis or significant trophic lesions, is crucial for optimal ESS outcomes.
• Refined patient selection criteria have improved the success rate of ESS in managing PVD.